Home / API Services & Chemical Development /

Immobilised CalB for Pharmaceutical Manufacturing

A proven biocatalyst for scalable, cost‑efficient and sustainable API & intermediate synthesis – enabling cleaner chemistry at commercial scale.

Immobilised CalB (Candida antarctica Lipase B) is a proven, industrial biocatalyst used at multi‑kilogram to tonne scale in pharmaceutical and intermediate manufacturing. Delivered in a stable, immobilised format, immobilised CalB enables high‑selectivity esterification and transesterification reactions under mild conditions; supporting reliable scale‑up, lower cost in use, and more sustainable processes.

In partnership with enginzyme, we support pharmaceutical manufacturers and CDMOs in evaluating, implementing, and scaling immobilised CalB‑based processes as a robust alternative to traditional chemical routes.

Why Immobilised CalB for Pharma?

Designed for real manufacturing environments, immobilised CalB is already embedded in commercial API and pharmaceutical intermediate supply chains, valued for its reliability, reusability, and supply security.

Key advantages include:

  • High selectivity and consistent performance for esterification and transesterification reactions.
  • Immobilised, mechanically robust format suitable for repeated batch operation.
  • Reusability across multiple reaction cycles, reducing cost in use.
  • Stable performance in organic solvents and mixed hydrophobic/hydrophilic systems.
  • Lower operating temperatures, improving safety and energy efficiency.
  • Reduced reliance on harsh reagents, supporting greener chemistry.
Contact us
CalB
CalB Boxes — Accordion + Anti‑Orphan

Proven Performance with Immobilised CalB Technology​

High activity. High productivity. High confidence.

Immobilised CalB formulations have demonstrated:

● Over 50% higher lipase activity and productivity versus incumbent formulations
● Over 99% conversion in esterification reactions, reducing downstream purification
● Consistent performance across multiple reaction cycles, enabling reuse
● Shorter reaction times with low catalyst loadings, improving throughput

These attributes make immobilised CalB particularly well‑suited to API intermediates, chiral building blocks, and functional esters used in pharmaceutical manufacturing.

Simplifying Processes, Reducing Waste

From complex chemical routes to streamlined biocatalysis

Compared to conventional chemical esterification, immobilised CalB‑enabled enzymatic processes:

● Eliminate unnecessary downstream steps
● Reduce energy demand through milder reaction conditions
● Enable catalyst recovery and reuse
● Lower waste generation and solvent usage

This translates directly into clear ROI, reduced environmental footprint, and simpler, more robust manufacturing processes.

Built for Scale and Supply Security​

Immobilised CalB solutions are suitable from laboratory evaluation through to industrial manufacture, supporting:

● Pharma and generic API manufacturers
● CDMOs producing APIs and intermediates
● Fine chemical and pharmaceutical intermediate suppliers

Multi‑kg to tonne scale supply ensures immobilised CalB can be confidently integrated into commercial manufacturing strategies.

Sustainability That Delivers Real Value​

Sustainability is not an add‑on—it is embedded in immobilised CalB‑enabled processes:

● Lower energy consumption via mild operating conditions
● Reduced waste and fewer purification steps
● Extended catalyst lifetime, improving material efficiency
● Support for green chemistry initiatives aligned with pharma ESG goals

How We Support You

At Almac Sciences, we go beyond enzyme supply. We support:

  • Feasibility and route evaluation using immobilised CalB​
  • Process development and optimisation​
  • Scale‑up and technology transfer​
  • Secure, long‑term supply strategies

Our team works with process chemists, procurement, and manufacturing leaders to ensure immobilised CalB delivers measurable technical and commercial value.

Immobilised CalB - How We Support You

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies